-
ACE2: S1 RBD interaction-targeted peptides and small molecules as potential covid-19 therapeutics
Chitsike, L., Krstenansky, J. & Duerksen-Hughes, P. J., 2021, In: Advances in Pharmacological and Pharmaceutical Sciences. 2021, 1828792.Research output: Contribution to journal › Article › peer-review
Open Access -
A high-content AlphaScreen™ identifies E6-specific small molecule inhibitors as potential therapeutics for HPV+ head and neck squamous cell carcinomas
Chitsike, L., Yuan, C. H., Roy, A., Boyle, K. & Duerksen-Hughes, P. J., Mar 1 2021, In: Oncotarget. 12, 6, p. 549-561 13 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics
Chitsike, L. & Duerksen-Hughes, P., Dec 2021, In: Virology Journal. 18, 1, 154.Research output: Contribution to journal › Review article › peer-review
Open Access